Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals

Journal of Medical Virology

Volumn 58, Issue 3, 1999, Pages 239-246

  Jackson, Margaret ^b   Smith, Belinda ^d   Bevitt, Debra J ^d   Steward, Michael ^a   Toms, Geoffrey L ^d   Bassendine, Margaret F ^d   Diamond, Austin G ^c  

^a Novacastra Laboratories   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d NONE

Author keywords

Dendritic cells; HLA A * 0201; Synthetic peptides

Indexed keywords

CORE PROTEIN; EPITOPE; SYNTHETIC PEPTIDE;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; FEMALE; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; NONHUMAN; VIRUS CORE;

CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES, CYTOTOXIC; VIRAL CORE PROTEINS;

EID: 0033002851     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199907)58:3<239::AID-JMV9>3.0.CO;2-V     Document Type: Article

References (39)

1. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzerwilliams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T-lymphocytes. Science 274:94-96.
2. Battegay M, Fikes J, Di Bisceglie A, Wentworth P, Sette A, Celis E, Ching W, Grakoui A, Rice C, Kurokohchi K, et al. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 69:2462-2470.
3. Bennink JR, Yewdell JW. 1990. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Curr Top Microbiol Immunol 163:153-184.
4. Bhardwaj N, Young JW, Nisanian AJ, Baggers J, Steinman RM. 1993. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J Exp Med 178:633-642.
5. + T-cells. J Clin Invest 94:797-807.
6. Cerny A, Chisari F. 1994. Immunological aspects of HCV infection. Intervirology 37:119-125.
7. Cerny A, McHutchison J, Pasquinelli C, Brown M, Brothers M, Grabscheid B, Fowler P, Houghton M, Chisari F. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95:521-530.
8. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
9. Deng Y, Yewdell J, Eisenlohr L, Bennick J. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol 158:1507-1515.
10. Hill A, Ploegh H. 1995. Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc Natl Acad Sci USA 92:341-343.
11. Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ishikawa T, Ohnishi S, Aikawa T, Tanaka N, Yazaki Y, Mitamura K, Imawari M. 1997. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25:705-712.
12. Ishak K, Baptista A, Bianchi L, Callea F, Degroote J, Gudat F, Denk H, Desmet V, Korb G, Macsween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. 1995. Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
13. Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039-1044.
14. Koziel M, Dudley D, Wong J, Dienstag J, Houghton M, Ralston R, Walker B. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339-3344.
15. Koziel M, Dudley D, Afdhal N, Grakoui A, Rice C, Choo Q, Houghton M, Walker B. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96:2311-2321.
16. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. 1997. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 176:859-866.
17. Lalvani A, Brookes R, Hambleton S, Britton W, Hill A, McMichael A. 1997. Rapid effector function in CD8+ memory T cells. J Exp Med 186:859-865.
18. Lasarte JJ, GarciaGranero M, Lopez A, Casares N, Garcia N, Civeira MP, BorrasCuesta F, Prieto J. 1998. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology 28:815-822.
19. Markowicz S, Engleman EG. 1990. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest 85:955-961.
20. + CTLs from naive precursors. J Immunol 153:996-1003.
21. Milton ID, Watson JP, Guo K, Carter MJ, Bassendine MF, Toms GL. 1995. Prokaryotic expression and analysis of the antibody response to a Newcastle isolate of the core gene of hepatitis C. J Med Virol 45:253-258.
22. Nelson D, Marousis C, Davis G, Rice C, Wong J, Houghton M, Lau J. 1997. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 158:1473-1481.
23. Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JYN. 1998. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology 28:225-230.
24. Okada CY, Rechsteiner M. 1982. Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell 29:33-41.
25. Oldstone MB. 1994. The role of cytotoxic T lymphocytes in infectious disease: history, criteria, and state of the art. Curr Top Microbiol Immunol 189:1-8.
26. Parker K, Bednarek M, Coligan J. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side chains. J Immunol 152:163.
27. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453-459.
28. Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel RM. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633.
29. Rehermann B, Chang K, McHutchinson J, Kokka R, Houghton M, Rice C, Chisari F. 1996a. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 70:7092-7102.
30. Rehermann B, Chang K, McHutchison J, Kokka R, Houghton M, Chisari F. 1996b. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98:1432-1440.
31. Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard V, Feinstone S, Berzofsky J. 1995. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol 154:2733-2742.
32. Steinman RM. 1991. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9:271-296.
33. Taylor PM, Askonas BA. 1986. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58:417-420.
34. Tong M, El-Farra N, Reikes A, Co R. 1995. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466.
35. Townsend A, Bodmer H. 1989. Antigen recognition by class I-restricted T lymphocytes. Ann Rev Immunol 7:601-624.
36. Wentworth P, Sette A, Cells E, Sidney J, Southwood S, Crimi C, Stitely S, Keogh E, Wong N, Livingston B, Alazard D, Vitiello A, Grey H, Chisari F, Chesnut R, Fikes J. 1996. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int Immunol 8:651-659.
37. Young JW, Steinman RM. 1988. Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells. Cell Immunol 111:167-182.
38. + helper T cells. J Exp Med 171:1315-1332.
39. Zinkernagel RM, Moskophidis D, Kundig T, Oehen S, Pircher H, Hengartner H. 1993. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol Rev 133:199-223.